The inhibitor also abolished the clonogenic growth of human renal cell carcinoma (RCC) under hypoxic conditions, and reduced cyclosporine A-induced expression of VEGF and IRE1 activation, which is of particular therapeutic interest in the context of organ transplantation [129]. The gene discussed is ERN1; the disease is renal cell carcinoma.